Filing Details
- Accession Number:
- 0001181431-11-028854
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-11 17:34:43
- Reporting Period:
- 2011-05-10
- Filing Date:
- 2011-05-11
- Accepted Time:
- 2011-05-11 16:34:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1325879 | Aveo Pharmaceuticals Inc | AVEO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1486420 | A Ronald Depinho | C/O Aveo Pharmaceuticals, Inc. 75 Sidney Street Cambridge MA 02139 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-05-10 | 5,000 | $16.54 | 225,012 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-05-10 | 5,000 | $16.54 | 217,512 | No | 4 | S | Indirect | by spouse |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | by spouse |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2011.
- The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.50 to $16.70, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on March 8, 2011.
- These shares are held by the reporting person's spouse. The reporting person disclaims all beneficial ownership over all such shares, except to the extent of his pecuniary interest therein.
- The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.50 to $16.71, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
Billionaire Hedge Funds
